Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Ref Type | |||||||||||||
PMID | |||||||||||||
Authors | Kathleen N. Moore, Suzanne Fields Jones, Carla Kurkjian, Hendrik-Tobias Arkenau, Jeffrey R. Infante, Shubham Pant, Howard A. Burris, D. Scott McMeekin, Jay Gibbons, Kimberly Harrow, Chris Liang, Sara Ramsey, Johanna C. Bendell | ||||||||||||
Title | Phase I, first-in-human trial of an oral VEGFR tyrosine kinase inhibitor (TKI) x-82 in patients (pts) with advanced solid tumors. | ||||||||||||
|
|||||||||||||
URL | http://meetinglibrary.asco.org/content/98269-114 | ||||||||||||
Abstract Text | J Clin Oncol 30, 2012 (suppl; abstr 3041) |
Molecular Profile | Treatment Approach |
---|
Gene Name | Source | Synonyms | Protein Domains | Gene Description | Gene Role |
---|
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|
Gene | Variant | Impact | Protein Effect | Variant Description | Associated with drug Resistance |
---|
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|